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Abstract
Background: The dominant method of reporting findings from diagnostic and surgical procedures is the narrative
report. In cancer care, this report inconsistently provides the information required to understand the cancer and
make informed patient care decisions. Another method of reporting, the synoptic report, captures specific data
items in a structured manner and contains only items critical for patient care. Research demonstrates that synoptic
reports vastly improve the quality of reporting. However, synoptic reporting represents a complex innovation in
cancer care, with implementation and use requiring fundamental shifts in physician behaviour and practice, and
support from the organization and larger system. The objective of this study is to examine the key interpersonal,
organizational, and system-level factors that influence the implementation and use of synoptic reporting in cancer
care.
Methods: This study involves three initiatives in Nova Scotia, Canada, that have implemented synoptic reporting
within their departments/programs. Case study methodology will be used to study these initiatives (the cases) in-
depth, explore which factors were barriers or facilitators of implementation and use, examine relationships
amongst factors, and uncover which factors appear to be similar and distinct across cases. The cases were selected
as they converge and differ with respect to factors that are likely to influence the implementation and use of an
innovation in practice. Data will be collected through in-depth interviews, document analysis, observation of
training sessions, and examination/use of the synoptic reporting tools. An audit will be performed to determine/
quantify use. Analysis will involve production of a case record/history for each case, in-depth analysis of each case,
and cross-case analysis, where findings will be compared and contrasted across cases to develop theoretically
informed, generalisable knowledge that can be applied to other settings/contexts. Ethical approval was granted for
this study.
Discussion: This study will contribute to our knowledge base on the multi-level factors, and the relationships
amongst factors in specific contexts, that influence implementation and use of innovations such as synoptic
reporting in healthcare. Such knowledge is critical to improving our understanding of implementation processes in
clinical settings, and to helping researchers, clinicians, and managers/administrators develop and implement ways
to more effectively integrate innovations into routine clinical care.
Keywords: Cancer, Synoptic report, Innovation, Implementation
* Correspondence: robin.urquhart@cdha.nshealth.ca
1Cancer Outcomes Research Program, Cancer Care Nova Scotia, Victoria
Building, QEII Health Sciences Center, 1276 South Park Street, Halifax, Nova
Scotia, Canada
Full list of author information is available at the end of the article




© 2012 Urquhart et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.Background
Cancer treatment and management have become
increasingly complex over the past two decades, with
therapeutic decisions often based on input from a multi-
disciplinary team that consists of radiologists, surgeons,
pathologists, and oncologists [1]. For patients with sus-
pected or confirmed cancer, clear and thorough record-
ing of diagnostic and surgical procedures and findings
support accurate diagnosis and staging. Such recording
also facilitates more accurate prognosis estimates, post-
operative management, and adjuvant treatment plan-
ning. The dominant method of reporting findings from
diagnostic tests/procedure s ,s u r g e r y ,a n dp a t h o l o g y
examinations is the narrative report, which is a free text,
descriptive account of the procedure, suspected or con-
firmed findings, and proposed treatment. Physicians dic-
tate this report, often through automated telephone
systems, and professional transcriptionists transcribe the
oral description into a written document that is even-
tually placed into a patient’s medical record. Research
has demonstrated that narrative reports inconsistently
provide the information required to understand the dis-
ease and make informed patient care decisions [2-7].
Another method of reporting, the synoptic report, cap-
tures data items in a structured manner and contains only
items critical for understanding the disease and subse-
quent impacts on patient care. There is a spectrum of
what is generally considered a synoptic report [1], from
synoptic-like structured templates without scientifically
validated elements to sophisticated electronic systems with
drop-down menus, discrete data fields, standardized lan-
guage, automated coding processes, and strong evidentiary
basis. A landmark study in the early 1990s, which audited
p a t h o l o g yp r a c t i c ep a t t e r n sa t 532 institutions in three
countries, found that the one practice associated with
completeness of pathology reporting for colorectal cancer
specimens was use of a standardized report or checklist
[8]. Since that time, researchers have consistently demon-
strated that synoptic reports (even paper-based ‘checklist’
formats) vastly improve the quality of pathology reporting
in colorectal [1,2,9-13], breast [1,9,14-16], lung [1,17],
prostate [1], pancreatic [18], melanoma [19], and hemato-
lymphoid cancers [20]. More recently, synoptic reporting
has been shown to improve the quality of surgical report-
ing for a variety of malignancies, including colorectal [7],
breast [21], thyroid [22], and pancreatic cancers [23], as
well as non-malignant operative procedures [24,25].
Electronic synoptic reporting tools also lead to health
system efficiencies compared to the dominant, dictated
method of reporting [25-27]. Laflamme et al. [25] showed
that use of synoptic templates accelerated the mean time
for a verified surgical report to reach the patient’sm e d i -
cal record by 800-fold compared to narrative reporting
(28 minutes versus > 14 days, respectively). Moreover,
the mean time from the end of the surgery to initiating
the report was substantially less when using synoptic
templates (0.43 hours) versus dictation (9.7 hours). Simi-
lar efficiencies were demonstrated in subsequent studies
[26,27]. In a Canadian study, for example, 97% of synop-
tic reports were finalized, placed in the patient’sm e d i c a l
record, and sent to all health professionals involved in
the patient’s care within 24 hours of surgery compared to
a mean of 90 days for narrative reports [26]. Researchers
have also estimated considerable cost-savings through
the elimination of transcription services [25,26].
Beyond improving completeness of reporting and
availability/immediacy of reports, synoptic reporting
tools have the potential to improve quality of care by
integrating practice guidelines/best evidence into report
templates [21,26] and providing an efficient, real-time
mechanism to generate data from the diagnostic and
peri-operative periods [21,26,28,29]. These data may be
used to provide real-time performance feedback to phy-
sicians and surgeons as well as enable improved process
and outcomes measurement. International jurisdictions
are increasingly endorsing synoptic reporting, including
actively supporting/funding the implementation of
synoptic templates [30-32] and providing commendation
status to pathology labs that include a synoptic synopsis
of scientifically validated data elements in their reports
[33]. In addition, the professional pathology colleges in
Canada, US, UK, and Australia have formalized a colla-
boration to develop common, internationally agreed-
upon, standardized cancer reporting protocols [34].
The synoptic report represents a complex innovation
(i.e., new knowledge, tool, or practice) in cancer care,
with its implementation and use requiring fundamental
shifts in physician behaviour and practice culture [35] as
well as support from the organization (e.g., changes in
institutional policies/processes) and larger system (e.g.,
governance arrangements, integration with health infor-
mation technology infrastructure). Despite the demon-
strated benefits, some physicians have reported
reluctance to use synoptic reporting tools, with concerns
including lack of flexibility in reporting complex proce-
dures/cases [36,37], the prospect of being monitored
[36], and discomfort with using information technology
[37,38]. Changing physician reporting practice is a com-
plex undertaking that requires comprehensive
approaches at different levels of the health system [39].
This may be particularly true for narrative reporting, a
practice that has existed for millennia [40].
Implementing new practices in healthcare organizations
Knowledge translation (KT) research has largely focused
on potentially useful strategies (e.g., opinion leaders,
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adoption and uptake of evidence (e.g., clinical practice
guidelines) into practice [41]. Most of these strategies
fall within the realm of individual-level interventions
[39,42-44], with the target being ‘autonomous’ clinicians
who are deemed to be more-or-less independent in
their capacity to assemble and apply knowledge to mod-
ify their practices [41]. Despite the sizable amount of lit-
erature in this area, however, numerous systematic
reviews have been unable to demonstrate which of these
strategies work best, or even consistently, across clinical
settings [43-45]. Many researchers have emphasized the
unpredictable, slow, and haphazard nature of research
implementation and use processes, with interventions
working some of the time in some situations, but not at
other times in seemingly similar situations [41,42,46],
and the reasons for these differences unclear [47].
In reality, many organizational and socio-political (e.g.,
inter-organizational networks, funding arrangements)
factors affect whether individuals in clinical settings
actually make changes in their practice [41,47-50].
Much research has demonstrated the importance of
organizational characteristics (e.g., culture, leadership,
management support, evaluation/feedback mechanisms,
and presence of champions) to implementation efforts
in healthcare settings [41,51-65]. Moreover, many of the
defining features of healthcare systems, including the
range and diversity of stakeholders, complex govern-
ance/resource arrangements, and professional autonomy
and specialization of many of its staff, result in many
d i f f e r e n tc u l t u r e sa n dn o r m sa sw e l la sh i g hl e v e l so f
interdependency amongst professionals in the system
[66,67].
Consequently, many implementation processes in
healthcare organizations will also be characterized by a
high degree of interdependency amongst organizational
members [68,69]. Indeed, many innovations introduced
in healthcare will require coordinated use by many indi-
viduals and professional groups to achieve benefits (elec-
tronic medical records are one example). These
individuals are situated in organizational relationships
wherein the implementation and use of a new tool or
practice will ultimately be influenced by many interperso-
nal processes, including ‘coalition building,’ rhetoric, and
persuasion [70,71]. Thus, while individual-level interven-
tions are important to change clinical practice, the com-
plex nature of healthcare organizations means individual-
level interventions alone cannot change clinical practice
in a widespread, sustainable way [39,48,72-75].
Understanding the dynamics of innovations in organi-
zations has a long history in management and organiza-
tional sciences [76]. Rogers [77] has conceptualized the
innovation-decision process as one that unfolds in dis-
tinct stages whereby an organization moves from initial
awareness or knowledge of an innovation to eventually
successfully integrating the innovation into ongoing pro-
cesses (or, alternatively, rejecting the innovation). Con-
trary to this perspective, extensive longitudinal study of
innovation processes led Van de Ven et al. [78] to
describe the ‘innovation journey’ as a non-linear cycle
during which ideas are developed (or adapted) and put
into practice by people who, through their relationships
and negotiations with others, make the changes neces-
sary to implement the innovation within a specific orga-
nizational context. They highlight that people and
relationships are instrumental to this journey, which is
characterized by many divergent and convergent activ-
ities wherein the initial idea often leads to multiple
ideas/actions, setbacks and delays occur frequently, staff
experience high levels of elation and frustration, notions
of success change, and new interdependencies are estab-
lished that affect the wider organization. This broader
‘systems’ perspective [78,79] has recently made its way
into KT dialogue and debate [49], challenging our think-
ing of a linear view of KT (e.g., researcher-push model)
and moving us toward one that is much more contex-
tual, relational, and ‘living’ in nature.
Research objective
The objective of this study is to examine the key inter-
personal, organizational, and system-level factors (here-
after referred to as ‘multi-level’ factors) that influence
the implementation and use of synoptic reporting in
three specific cases of cancer care. The interpersonal
level relates to the relational aspects at the level of the
implementation team/program: e.g., teamwork and team
dynamics, communication, partner engagement, coali-
tion building, power dynamics, and use of rhetoric and
persuasion to accomplish goals/tasks. The organizational
level relates to institutional (i.e., hospital) factors that
influence implementation and behaviour change: e.g.,
organizational culture, leadership, management, intra-
organizational relationships, evaluation capacity/
mechanisms, implementationp o l i c i e sa n dp r a c t i c e s ,
infrastructure, and presence of champions. The system
level refers to the broader sociopolitical context: e.g.,
policies such as financial incentives/disincentives,
resource and governance arrangements, and inter-orga-
nizational norms and networks.
This study involves three initiatives (the cases) in
Nova Scotia, Canada, that have implemented a synoptic
reporting tool within their departments/programs. The
examination of each case will involve answering the fol-
lowing specific research questions:
1. What, if any, common factors affected implementa-
tion and use across cases? How was it that these factors
‘transcended’ the different contexts (setting, timing, and
‘actors’ involved)?
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which were not found in other cases, that affected
implementation and use? If so, what are they and what
are their specific relationships to the setting, timing, and
actors?
T h eo u t c o m eo ft h i ss t u d yw i l lb ead e s c r i p t i v ea n d
explanatory account of the multi-level factors that influ-
ence the implementation and use of synoptic reporting
in cancer care.
Methodology
Case study methodology (CSM) [80,81] will be used to
study the three synoptic reporting cases in-depth,
explore which factors were barriers or facilitators of
implementation and use, examine relationships amongst
factors, and uncover which factors appear to be similar
(and distinct) across cases. CSM permits the rigorous
study of a contemporary phenomenon within its real-life
context [81], and of the complex interactions between
the social actors and their actions and environments
[82]. Case studies typically focus on ‘how’ and ‘why’
questions and explore multiple dimensions of some par-
ticular phenomenon. Flyvbjerg [83] argues that such in-
depth study (of real cases in specific contexts) may be
pivotal to transitioning from a novice to an expert
understanding of the phenomenon.
This complexity means that case study researchers
deal with distinct contexts whereby there are more vari-
ables of interest than data points. As a result, case stu-
dies rely on multiple sources of evidence and benefit
from knowledge of the literature and existing theoretical
perspectives [81]. The use of multiple sources is vital to
CSM, as it permits corroboration (i.e., triangulation) of
findings and resultant interpretations [81]. The use of
existing theoretical perspectives helps guide data collec-
tion and analysis. Without a prior theoretical under-
standing, researchers risk spending considerable time
and effort gathering basic information and ‘providing
description without meaning’ (Hartley, cited in [84]).
Methods
This research will examine the implementation and use
of synoptic reporting tools for cancer care in Nova Sco-
tia, Canada, using an explanatory multiple-case design.
Explanatory case studies present data to explain how
and why events happened; the researcher interprets phe-
nomena by answering questions of how and why draw-
ing upon a theoretical basis [81].
Theoretical perspectives
The use of theoretical frameworks/perspectives provides
structure to the inquiry and analysis, and helps ensure
the findings from the case study are connected to and
informed by the broader body of literature. This
research is informed by the empirical and theoretical lit-
erature on research implementation and the diffusion/
management of innovations. In particular, three theore-
tical frameworks/perspectives have largely informed the
design of this study (see Table 1): Promoting Action on
Research Implementation in Health Services [50,60];
Organizational framework of innovation implementation
[59]; and ‘Systems’ thinking/change [49]
Importantly, these perspectives were not identified
with the aim of determining which is ‘best’ at explaining
implementation and use processes in the cases selected
for study. Rather, these perspectives, when taken
together, present a range of interpersonal, organiza-
tional, and system influences on practice change and
thus identify potentially important factors to study.
Sampling
In case study research, limiting one’s study to three or
four cases will help ensure that a researcher is able to
study each case in sufficient detail and depth [80,89]. In
this study, three cases will be studied: Synoptic reporting
in the Nova Scotia Breast Screening Program (NSBSP);
Synoptic reporting in the Colon Cancer Prevention Pro-
gram (CCPP); and Synoptic reporting in the Surgical
Synoptic Reporting Tools Project (SSRTP).
These cases have been sampled on the basis of repli-
cation logic [81] as well as Stake’s criteria [80]: relevance
to the phenomenon; provision of diversity; and provision
of good learning opportunities. Using replication logic,
these cases were selected as they converge and differ
with respect to factors that, based on the literature and
theoretical perspectives, are likely to influence the
implementation and use of an innovation in clinical
practice. For example, the implementation of all three
initiatives has involved formal leadership, relatively small
implementation teams, clinical champions, and the
development of monitoring and feedback mechanisms.
At the same time, the cases represent diverse contexts,
including differences in relevant professional groups (e.
g., specialties, disease sites), institutions (e.g., academic/
tertiary care centres, community hospitals), mode of
change (e.g., top-down, bottom-up), implementation
support and resource characteristics, and history/timing.
Data collection procedures
This study will use multiple data collection procedures,
gathering evidence across cases as well as across the var-
ious levels (interpersonal, organization, system) of each
case, to gain rich, detailed information about each case and
to increase the likelihood of achieving triangulation of data.
Interviews with key informants
One-on-one semi-structuredi n t e r v i e w sw i l lb ec o n -
ducted with key informants at the different levels of
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informants will be interviewed (see Table 2): users of
the synoptic reporting system (e.g., radiologists, gastro-
enterologists, surgeons); individuals directly involved in
planning or carrying out the implementation; organiza-
tional members relevant to the initiative; individuals
involved at the system level (e.g., funders, policy-
makers); and users of the final synoptic report (e.g.,
oncologists, coders). While the latter group may not
have been directly involved in implementation efforts,
their acceptance and use of the synoptic report is
important to widespread implementation and use. Some
informants may be asked to partake in several interviews
(e.g., initial and follow-up interviews) depending on the
case and data collected.
Patton [90] and Rubin and Rubin [91] will be used to
guide the interview design and research questions. Inter-
view questions will be adapted based on each case’su n i q u e
context as well as the person being interviewed and his/
her role in the implementation. The semi-structured for-
mat will permit the interviewer to remain focused so that
the research goals are achieved and the participant’s time
Table 1 Description of the three theoretical perspectives guiding the case study
Construct/Factor Description
Promoting Action on Research Implementation
in Health Services (PARiHS)
Evidence ’[K]nowledge derived from a variety of sources that has been subjected to testing and has found
to be credible’ [85]. Four sources of evidence are research, clinical experience, patient experience,
and local information.
Context The ‘environment or setting in which people receive healthcare services, or... the environment or
setting in which the proposed change is to be implemented’ [86]. Context consists of:
￿ Culture manifests itself through the values, beliefs, and assumptions embedded in organizations
and is reflected in ‘the way things are done around here’ [86].
￿ Leadership ‘summarizes the nature of human relationships such that effective leadership gives
rise to clear roles, effective teamwork, and effective organizational structures’ [86].
￿ Evaluation includes performance monitoring and feedback at the individual, team, and system
levels.
Facilitation A ‘technique by which one person makes things easier for others’ [60]. Facilitation models range
from doing for others to enabling others.
Organizational framework of innovation
implementation
Management support Managers’ commitment to the implementation process, including investments in quality
implementation policies and practices.
Financial resource availability The actual or potential resources that allow an organization or team adapt to, implement, and
sustain change.
Implementation policies and practices ’[T]he formal strategies (i.e., the policies) the organization uses to put the innovation into use and
the actions that follow from those strategies (i.e., the practices)’ [59].
Implementation climate ’Employees’ shared perceptions of the importance of innovation implementation within the
organization’ [87]. The extent to which employees view innovation use is ‘rewarded, supported,
and expected within their organization’ [88].
Innovation-values fit ’[T]he perceived fit between the innovation and professional or organizational values,
competencies and mission’ [59].
Champions ’Charismatic individuals with significant personal authority who identify with the innovation and
throw their weight behind its adoption and implementation’ [59].
The need for systems change*
Nature of knowledge ’The way in which participants (individuals) in the system understand the nature and
characteristics of the new piece of knowledge and accept it’ [49].
Local autonomy The extent to which individuals, team, and the unit involved ‘can make informed, autonomous
decisions about how they can use the new knowledge to improve outcomes’ [49].
(Re)Negotiation How individuals ‘negotiate and renegotiate relations with others (individuals, teams, internal,
external relations) in their system’ [49].
Resources How individuals ‘attract necessary resources to sustain the changes/improvements in practice’
[49]. Involvement of key stakeholders at various levels of the system is critical to controlling and
attracting resources.
*In this recent theoretical paper, Kitson [49] critiqued the critical social science, action science, diffusion of innovations, practice development, management of
innovations, and learning organizations and systems theories literature to explore the underlying assumptions and theories used to describe healthcare systems
and how knowledge is translated into practice.
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additional issues that may be pertinent to the current
research, but are not specifically addressed by the inter-
view script [90]. Following each interview, the questions
and responses will be reviewed to determine whether or
not the issues were answered in sufficient depth and, if
not, questions will be revised before the next interview
[91]. Though theoretical perspectives have been used to
guide this study, when information arises that conflicts
with these perspectives, we will depart from the interview
script and explore that particular concept/issue further. In
subsequent interviews, that issue will be integrated into
the script, if relevant in the context of that specific
informant.
One investigator (RU) will conduct all interviews. Each
interview will be audiotaped to ensure the data are retrie-
vable and captured in true form, and will be transcribed
verbatim by an experienced research coordinator.
Non-participant observation
Non-participant observation [90] will be utilized to
observe training sessions (format, quality of training) and
initial surgeon reactions to viewing/using the innovation.
Thus, these sessions will provide another opportunity to
collect data on surgeons’ perspectives on the innovation
and any barriers that surgeons perceive at the time of
training. These sessions will be conducted for one case
only (SSRTP) since the implementation of the surgical
synoptic report is ongoing, permitting prospective obser-
vation of user training and early support activities.
Document analysis
Document information will bes o u g h to u ta n da n a l y z e d
for each case. This includes project plans, team/organiza-
tional records related to synoptic reporting, training/sup-
port manuals, agendas and meeting minutes, formal/
informal evaluations conducted, and media or profes-
sional articles/newsletters on initiative. These records
will be reviewed to gain an historical and contextual per-
spective on the initiative and to corroborate and augment
evidence from both interviews and observations [81].
Where documentary evidence conflicts with findings
from other sources, we will attempt to resolve these con-
tradictions through further inquiry (e.g., follow-up with
informants, contact with implementation team).
Physical artifacts
Each synoptic reporting tool will be examined to gain
insight into the technical operations related to using the
system. This will entail inputting ‘test’ cases into the sys-
tem to experience tool use as well as viewing the final
synoptic report to observe its design/format. Field
notes/perceptions related to these experiences will be
used to corroborate and augment evidence (specifically
related to system/tool issues) from other sources.
Tool audits
Tool audits will be conducted to determine the propor-
tion of eligible clinicians using the synoptic reporting
tool and the proportion of eligible procedures at each
institution that were reported using the synoptic
Table 2 Proposed key informants
CASE* DESCRIPTION OF INFORMANTS
†
NSBSP ￿ 4-5 radiologists
￿ 3-4 implementation personnel (leaders, team members)
‡
￿ 3 organizational members (e.g., managers/directors of relevant departments)
￿ 2 executive- or funding-level decision-makers
￿ 2 report end-users (e.g., surgeons, coders)
CCPP ￿ 4-5 gastroenterologists/general surgeons
￿ 3-4 implementation personnel (leaders, team members)
‡
￿ 3 organizational members (e.g., managers/directors of relevant departments)
￿ 2 executive- or funding-level decision-makers
￿ 2 report end-users (e.g., surgeons, radiation oncologists, coders)
SSRTP ￿ 4-5 surgeons
￿ 3-4 implementation personnel (leaders, team members)
‡
￿ 3 organizational members (e.g., managers/directors of relevant departments)
￿ 2 executive- or funding-level decision-makers
￿ 2 report end-users (e.g., radiation oncologists, coders)
Minimum number of key informants = 42-48
*NSBSP = Nova Scotia Breast Screening Program; CCPP = Colon Cancer Prevention Program; SSRTP = Surgical Synoptic Reporting Tools Project.
†The specified number represents the minimal number of key informants per category.
‡Implementation personnel may be interviewed on several occasions (e.g., initial and follow-up interviews) depending on the case and data collected.
Urquhart et al. Implementation Science 2012, 7:12
http://www.implementationscience.com/content/7/1/12
Page 6 of 10reporting tool. This will entail an audit of the synoptic
reporting system/database as well as the relevant institu-
tional administrative system (e.g., admission/discharge/
transfer or operating room scheduling systems). The lat-
ter is required to determine the number of eligible pro-
cedures (e.g., endoscopies, surgeries) performed at that
institution in a specified period of time. Eligibility cri-
teria for the audits include the physician/surgeon is a
registered user on the synoptic reporting system and a
synoptic template is in use for the specific procedure (e.
g., lumpectomy for a malignant breast tumour).
Analysis
Yin [81] describes a number of important strategies of
case study analysis: developing case descriptions, relying
on theoretical frameworks/perspectives, using data from
multiple sources to augment and triangulate findings,
and examining rival explanations (i.e., other plausible
explanations for the findings; one rival explanation is
that psychological theories, such as the Theory of
Planned Behaviour [92], better explain implementation
in one or more of the cases studied). In this study, data
analysis will involve a three-stage process: production of
a case record/history for each case; in-depth analysis of
each case; and cross-case analysis. Like other qualitative
methodologies, analysis will begin with the first data
collected.
The first stage in the analytic process involves case
description. That is, a detailed case record (or history)
will be constructed for each case, including an in-depth
description of the history and context of the initiative
(including the impetus for the initiative, timeline, key
milestones and activities, and organization of the project
and implementation). This descriptive record will also
involve situating the case within its socio-political con-
text, particularly as it pertains to the provincial health-
care environment at the time of implementation.
The second stage will attempt to gain an in-depth
understanding of each synoptic reporting initiative and
how its experiences relate to the research objective as
well as the theoretical literature. This stage will involve
four analytic steps, which will be performed separately
for each of the three cases:
1. Thematic analysis for each of the following evidence
sources: interviews, documentary evidence, and observa-
tion. This analysis will follow the thematic analysis
approach presented by Braun and Clarke [93], involving
coding, collating codes, and generating, reviewing, and
refining themes. This approach is similar to the analysis
steps outlined by other researchers [89,91,94]. NVivo 9
(QSR International, Australia) will be used to help man-
age the data and aid in coding processes.
2. Cross-source analysis of themes. This analytic pro-
cess will compare, contrast, and synthesize findings
from each source to gain an understanding of how the
data from each source corroborates and augments data
from other sources, and to identify any areas of incon-
sistency and potential contradiction.
3. Explanation building to integrate evidence, link the
data to theoretical perspectives/literature, and develop a
deeper understanding of what occurred [81]. This tech-
nique involves iteratively and flexibly moving back and
forth between prior knowledge (theoretical perspectives,
other literature, research objective) and emerging, case-
specific data to get a deeper understanding and theoreti-
cally-sound explanation of what actually happened and
what was important throughout the process. An impor-
tant aspect of this process is considering and question-
ing other explanations. This process will enable us to
explain the implementation processes and the multi-
level factors that influenced implementation and use in
each case, and to examine existing theoretical constructs
and determine their appropriateness to these contexts.
In this way, we are able to explore existing theoretical
perspectives and revise theory, when appropriate.
4. Presentation of findings in relation to the overall
objective of the study, the theoretical perspectives, and
rival explanations.
The final stage will be to conduct a cross-case analysis
to compare and contrast themes between the cases.
Each case will be treated as a separate study and find-
ings (similarities and differences) will be compared
across cases to develop theoretically informed, generali-
sable knowledge on implementing innovations in clinical
practice that can be applied to other settings and con-
texts [81].
One critique of CSM is that case studies are subject to
confirmation bias, specifically toward confirmation of
preconceived ideas [83,95]. That is, researchers can
selectively describe and explain the studied events ‘to
support a favoured theory by underplaying evidence
inconsistent with the theory or supporting an alterna-
tive’ (p. 164) [95]. To minimize confirmation bias in this
study, all members of the research team will participate
in components of the analysis and compare their find-
ings. The focus will be to attend to all the evidence col-
lected, display and present the evidence and
interpretation(s) separately, consider other plausible
interpretations, and seek out additional evidence where
inconsistencies or contradictions exist [81]. Moreover,
the research team will strive to increase the ‘trustworthi-
ness’ of this study through detailed documentation and
description, including development and maintenance of
a case study database (consisting of a complete set of all
the data collected, along with the treatment of the data
during the research process), maintenance of a chain of
evidence (or audit trail), and rich descriptions of each
case and its context.
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Well-conducted case studies can make significant con-
tributions to the knowledge base of a particular area
[96] and have the potential to transform practice, either
within the case(s) being studied or across similar situa-
tions where individuals can learn from the findings [97].
Beyond informing the adoption and implementation of
synoptic reporting, we anticipate this study will add to
the development and application of theoretical knowl-
edge (particularly ‘systems’ perspectives) in the growing
KT field, and contribute to our knowledge base on the
multi-level factors, and the relationships amongst factors
in specific contexts, that influence implementation and
use of innovations in healthcare organizations. Both
contributions are important to improving our under-
standing of implementation processes in clinical settings,
and helping researchers, clinicians, and managers/
administrators develop and implement ways to more
effectively integrate innovations into routine clinical
care. This is especially relevant in the present healthcare
environment wherein new knowledge and technologies
are growing and changing rapidly, and the treatment
and management of many diseases are increasingly com-
plex and multidisciplinary.
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